Zhenyi Xue

2.8k total citations
45 papers, 2.1k citations indexed

About

Zhenyi Xue is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Zhenyi Xue has authored 45 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 14 papers in Molecular Biology and 11 papers in Epidemiology. Recurrent topics in Zhenyi Xue's work include Bioactive Compounds and Antitumor Agents (5 papers), Immune cells in cancer (5 papers) and Hepatitis C virus research (5 papers). Zhenyi Xue is often cited by papers focused on Bioactive Compounds and Antitumor Agents (5 papers), Immune cells in cancer (5 papers) and Hepatitis C virus research (5 papers). Zhenyi Xue collaborates with scholars based in China, United States and Australia. Zhenyi Xue's co-authors include Rongxin Zhang, Yurong Da, Zhi Yao, Zimu Zhang, Qi Zhang, Hongkun Liu, Xixi Cheng, X. Edward Guo, Huafeng Wang and Qing Xi and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Zhenyi Xue

45 papers receiving 2.1k citations

Peers

Zhenyi Xue
Yurong Da China
Meng Xia China
Junfei Jin China
Ye Cheng China
Gang Huang China
Jérémie Gautheron France
Ying Gao China
Qiao Cheng China
Daniela Verzella Italy
Yurong Da China
Zhenyi Xue
Citations per year, relative to Zhenyi Xue Zhenyi Xue (= 1×) peers Yurong Da

Countries citing papers authored by Zhenyi Xue

Since Specialization
Citations

This map shows the geographic impact of Zhenyi Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenyi Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenyi Xue more than expected).

Fields of papers citing papers by Zhenyi Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenyi Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenyi Xue. The network helps show where Zhenyi Xue may publish in the future.

Co-authorship network of co-authors of Zhenyi Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenyi Xue. A scholar is included among the top collaborators of Zhenyi Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenyi Xue. Zhenyi Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Crowley, Jeffrey, Richard G. Langley, Kenneth B. Gordon, et al.. (2022). Efficacy of Risankizumab versus Secukinumab in Patients with Moderate-to-Severe Psoriasis: Subgroup Analysis from the IMMerge Study. Dermatology and Therapy. 12(2). 561–575. 10 indexed citations
2.
Wang, Daowei, Jie Yan, Jun Xiao, et al.. (2021). Anlotinib Induces a T Cell–Inflamed Tumor Microenvironment by Facilitating Vessel Normalization and Enhances the Efficacy of PD-1 Checkpoint Blockade in Neuroblastoma. Clinical Cancer Research. 28(4). 793–809. 93 indexed citations
3.
Zhang, Lijuan, Kai Zhang, Jieyou Zhang, et al.. (2021). Loss of fragile site-associated tumor suppressor promotes antitumor immunity via macrophage polarization. Nature Communications. 12(1). 4300–4300. 30 indexed citations
4.
Morgan, Jake R., et al.. (2021). HCV Viral Load Greater Than 1000 IU/ml at Time of Virologic Failure in Direct-Acting Antiviral-Treated Patients. Advances in Therapy. 38(3). 1690–1700. 2 indexed citations
5.
Chen, Ying, Xin Li, Dongmei Zhou, et al.. (2020). Arctigenin protects mice from thioglycollate‐induced acute peritonitis. Pharmacology Research & Perspectives. 8(5). e00660–e00660. 6 indexed citations
6.
Xi, Qing, Jieyou Zhang, Guangze Yang, et al.. (2020). Restoration of miR-340 controls pancreatic cancer cell CD47 expression to promote macrophage phagocytosis and enhance antitumor immunity. Journal for ImmunoTherapy of Cancer. 8(1). e000253–e000253. 50 indexed citations
7.
Ren, Yinghui, X. Edward Guo, Jieyou Zhang, et al.. (2019). Parthenolide regulates oxidative stress‐induced mitophagy and suppresses apoptosis through p53 signaling pathway in C2C12 myoblasts. Journal of Cellular Biochemistry. 120(9). 15695–15708. 28 indexed citations
8.
Xue, Zhenyi, Qing Xi, Hongkun Liu, et al.. (2019). miR-21 promotes NLRP3 inflammasome activation to mediate pyroptosis and endotoxic shock. Cell Death and Disease. 10(6). 461–461. 116 indexed citations
9.
Cheng, Xixi, Huafeng Wang, Jinlai Yang, et al.. (2018). Arctigenin protects against liver injury from acute hepatitis by suppressing immune cells in mice. Biomedicine & Pharmacotherapy. 102. 464–471. 17 indexed citations
10.
Zhang, Zimu, Zhenyi Xue, Ying Liu, et al.. (2018). MicroRNA-181c promotes Th17 cell differentiation and mediates experimental autoimmune encephalomyelitis. Brain Behavior and Immunity. 70. 305–314. 56 indexed citations
11.
Huang, Bingqing, Huipeng Yang, Xixi Cheng, et al.. (2017). tRF/miR-1280 Suppresses Stem Cell–like Cells and Metastasis in Colorectal Cancer. Cancer Research. 77(12). 3194–3206. 201 indexed citations
12.
Ren, Yinghui, Yan Li, Jun Yan, et al.. (2017). Adiponectin modulates oxidative stress-induced mitophagy and protects C2C12 myoblasts against apoptosis. Scientific Reports. 7(1). 3209–3209. 60 indexed citations
13.
Wang, Huafeng, Huan Zhang, Zimu Zhang, et al.. (2016). Adiponectin-derived active peptide ADP355 exerts anti-inflammatory and anti-fibrotic activities in thioacetamide-induced liver injury. Scientific Reports. 6(1). 19445–19445. 59 indexed citations
14.
Zhang, Kai, Vivian Yawei Guo, Zhenzhen Ge, et al.. (2016). Adiponectin Suppresses T Helper 17 Cell Differentiation and Limits Autoimmune CNS Inflammation via the SIRT1/PPARγ/RORγt Pathway. Molecular Neurobiology. 54(7). 4908–4920. 61 indexed citations
15.
Zhang, Zhihui, Kai Zhang, Zhenyi Xue, et al.. (2015). Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling. Molecular Neurobiology. 53(8). 5356–5366. 47 indexed citations
16.
Zhang, Kai, Zhenzhen Ge, Zhenyi Xue, et al.. (2015). Chrysin suppresses human CD14+ monocyte-derived dendritic cells and ameliorates experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 288. 13–20. 30 indexed citations
17.
Xue, Zhenyi, Wen Li, Huafeng Wang, et al.. (2014). ZSTK474, a novel PI3K inhibitor, modulates human CD14+ monocyte-derived dendritic cell functions and suppresses experimental autoimmune encephalomyelitis. Journal of Molecular Medicine. 92(10). 1057–1068. 12 indexed citations
18.
Xue, Zhenyi, Zhenzhen Ge, Kai Zhang, et al.. (2013). Embelin Suppresses Dendritic Cell Functions and Limits Autoimmune Encephalomyelitis Through the TGF-β/β-catenin and STAT3 Signaling Pathways. Molecular Neurobiology. 49(2). 1087–1101. 28 indexed citations
19.
Peng, Meiyu, Bingqing Huang, Huan Zhang, et al.. (2013). Immune microenvironment profiles of tumor immune equilibrium and immune escape states of mouse sarcoma. Cancer Letters. 340(1). 124–133. 43 indexed citations
20.
Ge, Zhenzhen, Yurong Da, Zhenyi Xue, et al.. (2012). Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis. Experimental Neurology. 241. 56–66. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yurong Da Breakdown of academic impact, for papers by Meng Xia Breakdown of academic impact, for papers by Junfei Jin Breakdown of academic impact, for papers by Ye Cheng Breakdown of academic impact, for papers by Gang Huang Breakdown of academic impact, for papers by Jérémie Gautheron Breakdown of academic impact, for papers by Ying Gao Breakdown of academic impact, for papers by Qiao Cheng Breakdown of academic impact, for papers by Daniela Verzella
Rankless by CCL
2026